7730 Share Price Performance
JP¥0
0.00 (0.00%)
Price JP¥0
Fair ValueJP¥1,915.00
Share Pricen/a
Narrative Update • Jul 08
Mani, Inc. Stock Price
- 2 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
7730 Community Narratives
AN
Fair Value
·Fair Value JP¥1.92k 17.3% undervalued intrinsic discount
7730: Fair Value And Marginal Shifts Will Guide Future Performance
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value JP¥1.65k 4.1% undervalued intrinsic discount
China GPO Pricing And Distribution Shifts Will Pressure Margins And Earnings
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
China GPO Pricing And Distribution Shifts Will Pressure Margins And Earnings
Mani faces growing pressure in China as tighter hospital buying rules and a push for local suppliers could squeeze what it can charge and what it earns. At the same time, bigger distributors in Europe and a tricky factory expansion mean execution matters more than ever—and the upside case depends on whether recent demand stays strong.Read more
AN
JP¥1.65k
4.1% undervalued intrinsic discount
Fair Value
Revenue
8.94% p.a.
Profit Margin
22.24%
Future PE
20.99x
Price in 2029
JP¥1.92k
7730: Fair Value And Marginal Shifts Will Guide Future Performance
Mani makes surgical and dental tools, and the story now hinges on whether China sales recover after a recall while the company pushes harder into new overseas markets. See what could lift profits through new products and factory upgrades—and what could derail it, from trade frictions to a money-losing overseas unit.Read more
AN
JP¥1.92k
17.3% undervalued intrinsic discount
Fair Value
Revenue
9.19% p.a.
Profit Margin
22.71%
Future PE
23.69x
Price in 2029
JP¥2.22k
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
7730: Dividend Increase And Margin Outlook Will Shape Measured Return Prospects
Fair Value: JP¥1.65k 4.1% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
7730: Dividend Increase And Stable Assumptions Will Support Positive Future Outlook
Fair Value: JP¥1.92k 17.3% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Flawless balance sheet with solid track record and pays a dividend.
1 Risk
4 Rewards
Mani, Inc. Key Details
Last Reported Earnings
May 31, 2026
Next Reporting Earnings
Oct 15, 2026
- 66.55
- 66.54%
- 20.43%
- 0%
About 7730
- Founded
- 1956
- Employees
- 4140
- CEO
- WebsiteView website
Mani, Inc. engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally. The company operates through three segments: Surgical Products, Eyeless Needle Products, and Dental Products. The company offers surgical instruments, such as maniplers, vessel knives, ENT knives, and stainless wire needles; and ophthalmic instruments, including ophthalmic sutures and knives, and trocar kits for vitrectomy. It also provides surgical eyeless, eyed, taper point, cutting, ophthalmic needles; and dental instruments, such as endodontic instruments, endodontic rotary instruments, root canal obturation, diamond and carbide burs, finishing and polishing instruments, sutures and surgical needles, endodontic micro-accessories, and endodontic accessories. Mani, Inc. was founded in 1956 and is headquartered in Utsunomiya, Japan.
